The following is a listing of U.S. Food and Drug Administration (FDA) updates and activities:

• Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units by Hospira: Recall - Due to the Potential for Incomplete Crimp Seals 

• Hologic, Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices

• Vyaire Medical, Inc. Recalls the Twin Tube Due to The Potential of The Nozzle Separating During Patient Use

• Pres…

Sign Up for Free Trial

---

• Back
• MCN Blog